U.S. stocks rallied Wednesday as upbeat data on coronavirus treatment from Gilead Sciences offset fresh figures that showed U.S. economic growth contracted more than expected in the first quarter.
Stocks jump as investors weigh Gilead coronavirus treatment, GDP data
